AAAAAA

   
Results: 1-9 |
Results: 9
THE GENERAL-PRACTICE RESEARCH DATABASE
Authors: LAWSON DH SHERMAN V HOLLOWELL J
Citation: Dh. Lawson et al., THE GENERAL-PRACTICE RESEARCH DATABASE, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(6), 1998, pp. 445
POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 15-YEAR MORTALITY REPORT
Authors: BERESFORD J COLINJONES DG FLIND AC LANGMAN MJS LAWSON DH LOGAN RFA PATERSON KR VESSEY MP
Citation: J. Beresford et al., POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 15-YEAR MORTALITY REPORT, Pharmacoepidemiology and drug safety, 7(5), 1998, pp. 319-322
P53 PROTEIN AND MIB-1 EXPRESSION AS PROGNOSTIC MARKERS IN INVASIVE BREAST-CARCINOMA
Authors: MIDDLEMAN BR SCHILLER AB CLARK WS LAWSON DH COHEN C
Citation: Br. Middleman et al., P53 PROTEIN AND MIB-1 EXPRESSION AS PROGNOSTIC MARKERS IN INVASIVE BREAST-CARCINOMA, Modern pathology, 11(1), 1998, pp. 23-23
P53 PROTEIN AND MIB-1 EXPRESSION AS PROGNOSTIC MARKERS IN INVASIVE BREAST-CARCINOMA
Authors: MIDDLEMAN BR SCHILLER AB CLARK WS LAWSON DH COHEN C
Citation: Br. Middleman et al., P53 PROTEIN AND MIB-1 EXPRESSION AS PROGNOSTIC MARKERS IN INVASIVE BREAST-CARCINOMA, Laboratory investigation, 78(1), 1998, pp. 115-115
PHARMACOVIGILANCE IN THE 1990S
Authors: LAWSON DH
Citation: Dh. Lawson, PHARMACOVIGILANCE IN THE 1990S, British journal of clinical pharmacology, 44(2), 1997, pp. 109-110
EUROPEAN POSTMARKETING SURVEILLANCE OF RAMIPRIL IN HYPERTENSION .1. FEASIBILITY AND STUDY COHORT
Authors: LAWSON DH BRIDGMAN K DEBOCK GH GROBBEE DE HENSE HW BLOCK P PATERSON KR STONIER P
Citation: Dh. Lawson et al., EUROPEAN POSTMARKETING SURVEILLANCE OF RAMIPRIL IN HYPERTENSION .1. FEASIBILITY AND STUDY COHORT, European Journal of Clinical Pharmacology, 49(1-2), 1995, pp. 73-79
CONSERVATIVE TREATMENT OF EARLY-STAGE BREAST-CANCER - THE EMORY EXPERIENCE
Authors: SMITH RG LANDRY JC WOOD WC STYBLO T HUGHES LL LYNN M YORK RM POWELL RW BUTKER E LAWSON DH DAVIS LW
Citation: Rg. Smith et al., CONSERVATIVE TREATMENT OF EARLY-STAGE BREAST-CANCER - THE EMORY EXPERIENCE, American journal of clinical oncology, 17(4), 1994, pp. 348-352
RISKS OF BLEEDING PEPTIC-ULCER ASSOCIATED WITH INDIVIDUAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Authors: LANGMAN MJS WEIL J WAINWRIGHT P LAWSON DH RAWLINS MD LOGAN RFA MURPHY M VESSEY MP COLINJONES DG
Citation: Mjs. Langman et al., RISKS OF BLEEDING PEPTIC-ULCER ASSOCIATED WITH INDIVIDUAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Lancet, 343(8905), 1994, pp. 1075-1078
POSTMARKETING SURVEILLANCE VERSUS CLINICAL-TRIALS - WHICH BENEFITS THE PATIENT
Authors: LAWSON DH
Citation: Dh. Lawson, POSTMARKETING SURVEILLANCE VERSUS CLINICAL-TRIALS - WHICH BENEFITS THE PATIENT, Cardiology, 85, 1994, pp. 18-23
Risultati: 1-9 |